Pediatric blood & cancer · 2025
Raising Awareness: Real World Data On Palliative Care for Advanced Pediatric Cancers in Bavaria.
СтатьяНаблюдательное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nehls Nadja, Börner Maja, Ziegelmayer Sebastian, Haller Bernhard, Klot Felicitas Ferrari-von, Metzler Markus, Frühwald Michael C, Schlegel Paul-Gerhardt, Corbacioglu Selim, Feuchtinger Tobias, Lüttichau Irene Teichert-von
Аннотация
INTRODUCTION: Early integration of palliative care in children with cancer provides a variety of positive effects and is recommended at diagnosis. However, barriers often delay its implementation, and palliative care remains underutilized. This study provides real-world data on palliative care and integration in pediatric oncology in a high-income country.
METHODS: In this retrospective observational study, data derived from patients with refractory, progressive, or relapsed malignancies under the age of 18 years were collected from six German pediatric oncology centers (2017-2022). In addition to palliative data (onset, and duration of palliative care services, frequency of contact, place of death), disease entity, relapse/progression frequency, Karnofsky Performance Scale Index, therapy, and overall survival were collected. The frequency, timepoint of initiation and the duration of palliative care services were examined in relation to the disease trajectory (diagnosis to death/censoring) and tumor entity. Outcomes (overall survival, Karnofsky Performance Scale Index, place of death) were analyzed based on palliative care status.
RESULTS: Only 157 (42%) of the 373 patients received palliative care services. The mean duration of palliative involvement was 6.0 months with a mean disease trajectory of 31.4 months for patients receiving palliative care. On average, palliative care was initiated in the last third of the disease trajectory. Most of the 157 patients (65.9%) received palliative care during their final relapse/progression and only 16.8% at diagnosis. There was a significantly lower frequency of palliative care involvement for children with hematological malignancies.
CONCLUSION: Despite the substantial benefits, this study highlights significant delays and underutilization of palliative care for pediatric oncology patients, even in a high-income country.
METHODS: In this retrospective observational study, data derived from patients with refractory, progressive, or relapsed malignancies under the age of 18 years were collected from six German pediatric oncology centers (2017-2022). In addition to palliative data (onset, and duration of palliative care services, frequency of contact, place of death), disease entity, relapse/progression frequency, Karnofsky Performance Scale Index, therapy, and overall survival were collected. The frequency, timepoint of initiation and the duration of palliative care services were examined in relation to the disease trajectory (diagnosis to death/censoring) and tumor entity. Outcomes (overall survival, Karnofsky Performance Scale Index, place of death) were analyzed based on palliative care status.
RESULTS: Only 157 (42%) of the 373 patients received palliative care services. The mean duration of palliative involvement was 6.0 months with a mean disease trajectory of 31.4 months for patients receiving palliative care. On average, palliative care was initiated in the last third of the disease trajectory. Most of the 157 patients (65.9%) received palliative care during their final relapse/progression and only 16.8% at diagnosis. There was a significantly lower frequency of palliative care involvement for children with hematological malignancies.
CONCLUSION: Despite the substantial benefits, this study highlights significant delays and underutilization of palliative care for pediatric oncology patients, even in a high-income country.